NCT03755765View on ClinicalTrials.gov

Mechanisms of Preventing Antibiotic-Associated Diarrhea and the Role for Probiotics

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 23, 2019

Primary Completion Date

January 8, 2020

Study Completion Date

January 8, 2020

Conditions
Antibiotic-associated Diarrhea
Interventions
DRUG

Amoxicillin-Clavulanate 875 Mg-125 Mg Oral Tablet

Amoxicillin-Clavulanate 875 Mg-125 Mg Oral Tablet

BIOLOGICAL

BB-12

Bifidobacterium animalis subsp. lactis BB-12-supplemented yogurt

OTHER

Control

Yogurt without Bifidobacterium animalis subsp. lactis BB-12 (BB-12)

Trial Locations (1)

20007

Georgetown University Department of Family Medicine, Washington D.C.

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

University of Maryland, Baltimore

OTHER

lead

Georgetown University

OTHER

NCT03755765 - Mechanisms of Preventing Antibiotic-Associated Diarrhea and the Role for Probiotics | Biotech Hunter | Biotech Hunter